Galaxy Yuanhui Investment
VC Fund
Galaxy Yuanhui Investment is a VC fund focused on Industrial and Health Diagnostics. Galaxy Yuanhui Investment engages in alternative investment business.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Galaxy Yuanhui Investment invests in
Stages Galaxy Yuanhui Investment invests in
Countries Galaxy Yuanhui Investment invests in
Investment Focus
Industry
- Industrial 2 (22%)
- Health Diagnostics 2 (22%)
- Industrial Manufacturing 2 (22%)
- Retail 1 (11%)
- Medical 1 (11%)
Stage
- Series C 3 (33%)
- Series A 2 (22%)
- Series B 2 (22%)
- Series E 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Link Touch
|
Link Touch specializes in the research, development, and production of force sensors and force control products. It has deep experience accumulation and technical advantages in multi-dimensional force sensors, joint torque sensors, and robot force control technology. | $14.7M / Series C / Apr 14, 2026 | |
Spirit AI
|
Spirit AI develops 'Universal Brains' for robotics, specializing in general-purpose embodied models that bridge the gap between simulation and real-world deployment. These models provide robots with robust generalization and precise physical interaction capabilities across diverse environments. Technical efficacy is validated by theSpirit Series (notably Spirit v1.5), which currently leads the RoboChallenge global benchmarks. Through rigorous R&D, Spirit AI aims to integrate versatile robotic companions into the modern workforce, advancing the era of embodied AI. | $145.4M / Series A / Apr 07, 2026 | |
Tauren
|
Tauren is a domestic and hybrid design enterprise of analog and analog-digital chips. At present, the company has won the recognition of the top first-line customers and the strong support of the first-line investment institutions; in the future, it will continue to cultivate the analog and analog-digital hybrid design track, and provide highlycompetitive standardized products for the market landing demand. Provide customers with stable and first-class quality semiconductor products. | Series E / Jan 21, 2026 | |
Guangxing Technology
|
Guangxing Technology is a die-casting mold manufacturer specializing in engine blocks, transmission housings, flywheel housings, clutches, gearboxes, and other products used in ladders, automobiles, motorcycles, and other industries. | Venture - Series Unknown / Nov 24, 2023 | |
Uds China
|
Uds China is an enterprise that adopts digitalization as a business transformation strategy, they need a unified approach to the full suite of processes within the organization. | $21M / Series A / Jun 07, 2023 | |
Singlera
|
Singlera is a medical firm that is working to overcome the delay in early diagnosis of cancer through screening and auxiliary. | $44.9M / Series B / Jun 08, 2022 | |
GenomePrecision
|
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA"five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform. | $30.7M / Series C / Apr 19, 2021 | |
Synlight Crystal
|
Synlight Crystal achieves mass production of the 3rd generation semiconductor material SiC single crystal substrate. | Series C / Jan 21, 2021 | |
Sinopharm Online
|
Sinopharm Online has a pharmaceutical retail platform to provide users with online medication consultation, medical and health management consulting services, etc. The main sales cover Chinese and Western medicines and health products. , medical equipment, Chinese medicine | $42.5M / Series B / Apr 26, 2019 |
Co-Investors
Agibot
1 deal together
Ample Harvest Finance
1 deal together
CICC Capital
1 deal together
CPE
1 deal together
Cowin Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Galaxy Yuanhui Investment invest in?
Galaxy Yuanhui Investment invests primarily in Industrial, Health Diagnostics and Industrial Manufacturing startups, most often at Series C and Series A stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Galaxy Yuanhui Investment last invest?
The most recent investment recorded for Galaxy Yuanhui Investment closed in Apr 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
